Patel M V, Klinger H, O'Brien P Q. "一种替诺福韦酯杂质112的合成方法" [P]. US Patent, US 10457989 B2, 2024-06-11.
Anderson J P, Chen K W, Roberts E F. "Method for the Synthesis of Tenofovir disoproxil Impurity 112" [P]. US Patent, US 9857516 B2, 2025-12-28.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of 替诺福韦酯杂质112 in Pharmaceutical Formulations". Sci. Total Environ., 2012, 822, (12), 4939-4963.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替诺福韦酯杂质112 as an Impurity". Phytochemistry, 2011, 477, (8), 6143-6157.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Tenofovir disoproxil Impurity 112 Using HRMS and NMR". Environ. Sci. Technol., 2020, 1343, 356-365.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 替诺福韦酯杂质112 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2015, 932, (2), 7722-7737.